Expression of pRb, p53, p16 and cyclin D1 and their clinical implications in urothelial carcinoma.

Expression of pRb, p53, p16 and cyclin D1 and their clinical implications in urothelial carcinoma.

Item
http://www.wikidata.org/entity/Q34159723
Prognostic and Clinicopathological Significance of Downregulated p16 Expression in Patients with Bladder Cancer: A Systematic Review and Meta-AnalysisCDK4/6 Inhibitors in Cancer Therapy: A Novel Treatement Strategy for Bladder Cancer.Long-term oncologic outcomes after radical cystectomy for bladder cancer at a single institution.Immunohistochemistry and Fluorescence In Situ Hybridization Can Inform the Differential Diagnosis of Low-Grade Noninvasive Urothelial Carcinoma with an Inverted Growth Pattern and Inverted Urothelial Papilloma.Clinical Significance of Substaging and HER2 Expression in Papillary Nonmuscle Invasive Urothelial Cancers of the Urinary Bladder.Expression of p16 and pRB in invasive breast cancerImmunohistochemical evaluation of cell cycle regulators: impact on predicting prognosis in stage t1 urinary bladder cancer.The impact of cyclin D1 overexpression on the prognosis of bladder cancer: a meta-analysis.Current status of molecular markers for prognostication and outcome in invasive bladder cancer.Predictive markers in bladder cancer: do we have molecular markers ready for clinical use?Downregulation of the long non-coding RNA taurine-upregulated gene 1 inhibits glioma cell proliferation and invasion and promotes apoptosis.Companied P16 genetic and protein status together providing useful information on the clinical outcome of urinary bladder cancer.Pioglitazone Use and Risk of Bladder Cancer: an In Vitro Study.
P2860

Expression of pRb, p53, p16 and cyclin D1 and their clinical implications in urothelial carcinoma.

Item
http://www.wikidata.org/entity/Q34159723
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Expression of pRb, p53, p16 an ...... tions in urothelial carcinoma.
@ast
Expression of pRb, p53, p16 an ...... tions in urothelial carcinoma.
@en
Expression of pRb, p53, p16 an ...... tions in urothelial carcinoma.
@nl
type
label
Expression of pRb, p53, p16 an ...... tions in urothelial carcinoma.
@ast
Expression of pRb, p53, p16 an ...... tions in urothelial carcinoma.
@en
Expression of pRb, p53, p16 an ...... tions in urothelial carcinoma.
@nl
prefLabel
Expression of pRb, p53, p16 an ...... tions in urothelial carcinoma.
@ast
Expression of pRb, p53, p16 an ...... tions in urothelial carcinoma.
@en
Expression of pRb, p53, p16 an ...... tions in urothelial carcinoma.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Expression of pRb, p53, p16 an ...... tions in urothelial carcinoma.
@en
P2093
P2860
P304
P31
P356
10.3346/JKMS.2010.25.10.1449
P433
P478
P577
P5875
P698
P932